期刊文献+

HPLC法和UV分光光度法测定阿奇霉素片溶出度的方法比较 被引量:2

Comparison of HPLC and UV methods in determination of dissolution of azithromycin tablet
下载PDF
导出
摘要 目的采用HPLC和UV分光光度法测定阿奇霉素片溶出度,并从中选择适宜的方法。方法高效液相色谱法,采用ODS-50色谱柱,流动相为0.04M磷酸盐缓冲液(pH 11.0)-乙腈(400∶600),检测波长215 nm,柱温40℃,进样量20μL,溶出介质为磷酸盐缓冲液(pH6.5),转数为75 r/min,45 min取样。紫外分光光度法以磷酸盐缓冲液(pH6.0)为空白溶液及溶剂,检测波长为(482±2)nm,溶出介质为磷酸盐缓冲液(pH6.0),转速为100 r/min,45 min取样。结果溶出曲线方程式为:Y=0.001 3X+0.913,10 min时累计溶出量为92.3%(RSD=1.9%)。回归方程:A=0.007 5C-0.017 1,r=0.999 1。线性范围在17.9-89μg/mL,回收率为99.6%(RSD=0.4%)。结论两种方法都较为准确、简便,测得的溶出效果较好,溶出度结果也基本一致。 Objective To establish an effective and reliable determination for the dissolution of azithromycin tablet through comparing HPLC and UV methods.Methods ODS-50 column was used in HPLC method with phosphate buffer solution(pH 11.0)-acetonitrile(400∶600)as mobile phase.Column temperature was 40 ℃,detective wavelength was 215 nm,and injective volume was 20 μL.Phosphate buffer solution(pH 6.5)was used as dissolution medium.Rotatory speed was 75 rpm,and the sample was taken at 45 min.UV method:phosphate buffer solution(pH 6.0)was used as empty solvent,and detective wavelength was(482±2) nm.Dissolution medium for UV method was phosphate buffer solution(pH 6.0).Rotatory speed was 100 rpm,the sample was taken at 45 min.Results Linear range was 17.9~89.0 μg/mL,and recovery rate was 99.6%(RSD=0.4%).The average accumulated dissolution was 92.3%(RSD=1.9%)at 10 min.Conclusion The two methods are equivalent in determining dissolution of azithromycin tablet,and they are simple and accurate with good dissolution effect.
出处 《实用药物与临床》 CAS 2011年第4期303-305,共3页 Practical Pharmacy and Clinical Remedies
关键词 阿奇霉素片 溶出度 高效液相色谱法 紫外分光光度法 Azithromycin tablet Dissolution HPLC UV
  • 相关文献

参考文献1

二级参考文献2

  • 1中华人民共和国卫生部药典委员会,中华人民共和国药典(二部) .1995年版 [S],1995年,附录XIA页
  • 2张治锬,抗生素药品检验,1987年,17,62页

共引文献8

同被引文献20

  • 1王晓瑜,杜文民,王宏敏,徐建龙,戚秋鹏.164例阿奇霉素不良反应分析[J].中国现代医学杂志,2005,15(10):1550-1552. 被引量:48
  • 2谢沐风.改善溶出度评价方法,提高固体药物制剂水平[J].中国医药工业杂志,2005,36(7):447-451. 被引量:125
  • 3张晓华,李亚芳.阿奇霉素的临床应用进展[J].中国药业,2006,15(3):69-71. 被引量:50
  • 4Lo JB, Appel LE, Herbig SM, et al. Formulation design and phar- maceutical development of a novel controlled release form of azithro- mycin for single-dose therapy [ J ]. Drug Dev Ind Pharm, 2009,35 (12) : 1522-1529.
  • 5Simonoska CM, Glavas DM, Goracinova K. Chitosan coated Ca-algi- nate microparticles loaded with budesonide for delivery to the in- flamed colonic mucosa[ J ]. Eur J Pharm Biopharm, 2008,68 ( 3 ) : 565 -578.
  • 6Wittaya AS, Kruenate J, Prahsarn C. Preparation and in vitro evalua- tion of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone [ J ]. Int J Pharm, 2006,312 ( 1-2 ) : 113- 118.
  • 7Mennini N, Furlanetto S, Cirri M, et al. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-beta-cyclodextrin-PVP complex [ J ]. Eur J Pharm Biopharm, 2011,80(1 ) : 67-75.
  • 8Takka S, Gurel A. Evaluation of chitosan/alginate beads using ex- perimental design: formulation and in vitro characterization [J]. AAPS PharmSciTech, 2010,11 ( 1 ) : 460-466.
  • 9Motwani SK, Chopra S, Talegaonkar S, et al. Chitosan-sodium algi- nate nanoparticlcs as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation [ J ]. Eur J Pharm Biopharm, 2008,68 ( 3 ) : 513-525.
  • 10Girard D, Finegan SM, Dunne MW, et al. Enhanced efficacy of sin- gle-dose versus multi-dose azithromycin regimens in preclinical infec- tion models [ J ]. J Antimicrob Chemother, 2005,56 ( 2 ) : 365-371.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部